Member Exclusive

Retinal pigment epithelial cell manufacturing technique ready for Phase I clinical trials

A collaborative team from the National Institute of Health and the National Eye Institute (both MD, USA) has developed a novel GMP compliant manufacturing process for iPSC-derived retinal pigment epithelial cells, as a potential treatment opportunity for age-related macular degeneration.

Go to the profile of RegMedNet
Apr 30, 2019

Please sign in or register for FREE

No comments yet.